Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors

6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitors

US Patent 11458138 · Granted Oct 4, 2022

Estimated economic value: $49,982,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

One step synthesis for alkyl 2-fluoroacrylates2025
Sustained release delivery systems comprising traceless linkers2025
Aryl hydrocarbon receptor agonists and uses thereof2025
Safe box2025
Nitrogen-containing fused heterocyclic SHP2 inhibitor compound, preparation meth2025
Aryl hydrocarbon receptor agonists and uses thereof2024
(Pyridin-2-yl)amine derivatives as TGF-BETA R1 (ALK5) inhibitors for the treatme2024
Itraconazole analogs and use thereof2024
Hybrid cyclic libraries and screens thereof2024
Macrocyclic compounds and compositions, and methods of preparing and using the s2024
Fused tri-cyclic compound as PDE3/PDE4 dual inhibitor2024
Inducing cell death by hyperactivation of motility networks2024